Lucane’s Pheburane gets CHMP go-ahead
This article was originally published in Scrip
Executive Summary
The EU’s CHMP has granted a positive opinion to Lucane Pharma’s Pheburine, a hybrid of Ammonaps (sodium phenylbutyrate) which has been authorised in the EU since 1999.